Ulcerative Colitis Market grows at 5.4% CAGR (2025–2033), reaching US$ 12.79 Billion on rising biologic adoption, biosimilars, and personalized IBD therapies. North America leads the ulcerative ...
WAKEFIELD, MA, June 21, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Innovation Pharmaceuticals (IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announced the United States ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback